Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial

about

Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial

Item

http://www.wikidata.org/entity/Q58796581

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Design of the GutHeart-targeti ...... II, randomized clinical trial

@en

Design of the GutHeart-targeti ...... II, randomized clinical trial

@nl

type

Item

label

Design of the GutHeart-targeti ...... II, randomized clinical trial

@en

Design of the GutHeart-targeti ...... II, randomized clinical trial

@nl

prefLabel

Design of the GutHeart-targeti ...... II, randomized clinical trial

@en

Design of the GutHeart-targeti ...... II, randomized clinical trial

@nl

P1476

Design of the GutHeart-targeti ...... II, randomized clinical trial

@en

P2093

Anders Hovland

http://www.w3.org/2001/XMLSchema#string

Andrea Lorenzo

http://www.w3.org/2001/XMLSchema#string

Ayodeji O Awoyemi

http://www.w3.org/2001/XMLSchema#string

Cristiane C K Mayerhofer

http://www.w3.org/2001/XMLSchema#string

Ingebjørg Seljeflot

http://www.w3.org/2001/XMLSchema#string

Johannes R Hov

http://www.w3.org/2001/XMLSchema#string

Kaspar Broch

http://www.w3.org/2001/XMLSchema#string

Knut Tore Lappegård

http://www.w3.org/2001/XMLSchema#string

Marius Trøseid

http://www.w3.org/2001/XMLSchema#string

Samuel D Moscavitch

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

The Gut Microbiota in Immune-Mediated Inflammatory Diseases

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.

Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF).

The gut microbiome as novel cardio-metabolic target: the time has come!

An integrated catalog of reference genes in the human gut microbiome.

Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.

Gut microbiota and diabetes: from pathogenesis to therapeutic perspective.

Inflammatory mediators in chronic heart failure: an overview

Pathogenic Gut Flora in Patients With Chronic Heart Failure.

Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis.

P304

977-984

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1002/EHF2.12332

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pål Aukrust

Lars Gullestad

P5008

ScienceSource

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30088346

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

P932

6165929

http://www.w3.org/2001/XMLSchema#string